Resources

Innovative Closed Process CAR-T Cell Therapy Platform to Streamline Approach for Manufacturing with Great Predictability

Date: May 19, 2020 Time: 11 am EDT | 8 am PDT | 5 pm CEST For many years, the primary forms of cancer treatment have been chemotherapy, radiation, and surgery. An amazing breakthrough known as chimeric antigen receptor (CAR) T-cell therapy is being studied in the treatment of various types of cancer, including acute and …Read More >

Resource Type: Webinar
Resource Topic: Process Development

VIEW

World-Class AAV Vector Suspension Platform to Accelerate Commercialization to Market with Greater Predictability

WuXi Advanced Therapies launched a new world-class adenoassociated virus (AAV) vector suspension platform that complements integrated capabilities enabling cell and gene therapies to be developed, manufactured, and released faster and with greater predictability globally.

Resource Type: Webinar
Resource Topic: Clinical & Commercial Manufacturing Process Development

VIEW

INNOVATION IN GENE DELIVERY PLATFORMS, METHODS AND TECHNOLOGY

  In January, Phacilitate Leaders World & World Stem Cell Summit 2020 brought together the entire ecosystem of the advanced therapies industry from all corners of the globe to continue to build strong partnerships and collaborations to Miami, FL.  With so many great topics covered, common theme was innovation in research through to manufacturing and commercialization.  …Read More >

Resource Type: Video
Resource Topic: Process Development

VIEW

BioProcess International Ask The Expert Special Featured Article on AAV

  This article features: Bai-wei Gu, Head of the Cell Line Development Group, Juan Lagos, Head of Upstream Processing, and Matthew Weaver, Head of Downstream Processing at WuXi Advanced Therapies covering how to accelerate development and manufacturing platforms for viral vectors. Developing innovative advanced therapies is one of our greatest opportunities to dramatically improve patients’ …Read More >

Resource Type: Article
Resource Topic: Process Development

VIEW

Accelerating Viral Vectors Commercialization to Market through Suspension Platform with Greater Predictability

Abstract: Developing innovative advanced therapies is one of our greatest opportunities to dramatically improve patients’ lives. In this webinar, we will discuss our recent technical advancement on efficient viral vector manufacturing process development. From cell line development, suspension culture of HEK293 cells, transfection, to cell culture optimization and purification process development, a series of progress …Read More >

Resource Type: Webinar
Resource Topic: Clinical & Commercial Manufacturing Process Development

VIEW